BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

802 related articles for article (PubMed ID: 26199017)

  • 1. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
    Bonne S; Mazuski JE; Sona C; Schallom M; Boyle W; Buchman TG; Bochicchio GV; Coopersmith CM; Schuerer DJ
    J Am Coll Surg; 2015 Sep; 221(3):739-47. PubMed ID: 26199017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
    Schuerer DJ; Zack JE; Thomas J; Borecki IB; Sona CS; Schallom ME; Venker M; Nemeth JL; Ward MR; Verjan L; Warren DK; Fraser VJ; Mazuski JE; Boyle WA; Buchman TG; Coopersmith CM
    Surg Infect (Larchmt); 2007 Aug; 8(4):445-54. PubMed ID: 17883361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
    Darouiche RO; Raad II; Heard SO; Thornby JI; Wenker OC; Gabrielli A; Berg J; Khardori N; Hanna H; Hachem R; Harris RL; Mayhall G
    N Engl J Med; 1999 Jan; 340(1):1-8. PubMed ID: 9878638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly.
    Lorente L; Lecuona M; Jiménez A; Raja L; Cabrera J; Gonzalez O; Diosdado S; Marca L; Mora ML
    Am J Infect Control; 2016 Jan; 44(1):50-3. PubMed ID: 26412482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New choices for central venous catheters: potential financial implications.
    Shorr AF; Humphreys CW; Helman DL
    Chest; 2003 Jul; 124(1):275-84. PubMed ID: 12853534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of catheter-associated bloodstream infection after introduction of minocycline and rifampin antimicrobial-coated catheters in a pediatric burn population.
    Weber JM; Sheridan RL; Fagan S; Ryan CM; Pasternack MS; Tompkins RG
    J Burn Care Res; 2012; 33(4):539-43. PubMed ID: 22210071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bundle "plus": the effect of a multidisciplinary team approach to eradicate central line-associated bloodstream infections.
    Walz JM; Ellison RT; Mack DA; Flaherty HM; McIlwaine JK; Whyte KG; Landry KE; Baker SP; Heard SO;
    Anesth Analg; 2015 Apr; 120(4):868-76. PubMed ID: 24149581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in Central Line-Associated Bloodstream Infections Correlated With the Introduction of a Novel Silver-Plated Dressing for Central Venous Catheters and Maintained for 6 Years.
    Karlnoski R; Abboud EC; Thompson P; Oxner AZ; Sinnott JT; Marcet JE
    J Intensive Care Med; 2019 Jul; 34(7):544-549. PubMed ID: 29216782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of triple-lumen central venous catheters impregnated with silver nanoparticles (AgTive®) vs conventional catheters in intensive care unit patients.
    Antonelli M; De Pascale G; Ranieri VM; Pelaia P; Tufano R; Piazza O; Zangrillo A; Ferrario A; De Gaetano A; Guaglianone E; Donelli G
    J Hosp Infect; 2012 Oct; 82(2):101-7. PubMed ID: 22938728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorhexidine and silver sulfadiazine coating on central venous catheters is not sufficient for protection against catheter-related infection: Simulation-based laboratory research with clinical validation.
    Choi YJ; Lim JK; Park JJ; Huh H; Kim DJ; Gong CH; Yoon SZ
    J Int Med Res; 2017 Jun; 45(3):1042-1053. PubMed ID: 28534703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of chlorhexidine-silver sulfadiazine impregnated central venous catheters in patients receiving high-dose chemotherapy followed by peripheral stem cell transplantation.
    Maaskant JM; De Boer JP; Dalesio O; Holtkamp MJ; Lucas C
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):477-82. PubMed ID: 19453696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-Lumen Antibiotic-Impregnated Femoral Central Venous Catheters in Severely Burned Patients: An Investigation of Device Utility and Catheter-Related Bloodstream Infection Rates.
    Friedman BC; Mian MA; Mullins RF; Hassan Z; Shaver JR; Johnston KK
    J Burn Care Res; 2015; 36(4):493-9. PubMed ID: 25407386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use.
    Marciante KD; Veenstra DL; Lipsky BA; Saint S
    Am J Infect Control; 2003 Feb; 31(1):1-8. PubMed ID: 12548250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs.
    Lorente L; Lecuona M; Jiménez A; Santacreu R; Raja L; Gonzalez O; Mora ML
    Am J Infect Control; 2014 Mar; 42(3):321-4. PubMed ID: 24581021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CATheter Infections in CHildren (CATCH): a randomised controlled trial and economic evaluation comparing impregnated and standard central venous catheters in children.
    Harron K; Mok Q; Dwan K; Ridyard CH; Moitt T; Millar M; Ramnarayan P; Tibby SM; Muller-Pebody B; Hughes DA; Gamble C; Gilbert RE
    Health Technol Assess; 2016 Mar; 20(18):vii-xxviii, 1-219. PubMed ID: 26935961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised study.
    Camargo LF; Marra AR; Büchele GL; Sogayar AM; Cal RG; de Sousa JM; Silva E; Knobel E; Edmond MB
    J Hosp Infect; 2009 Jul; 72(3):227-33. PubMed ID: 19443078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Minocycline/Rifampin vs Chlorhexidine/Silver Sulfadiazine-Impregnated Central Venous Catheters.
    Mermel LA
    J Am Coll Surg; 2015 Oct; 221(4):891-2. PubMed ID: 26364070
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian sites.
    Lorente L; Lecuona M; Jiménez A; Lorenzo L; Santacreu R; Ramos S; Hurtado E; Buitrago M; Mora ML
    Am J Infect Control; 2015 Jul; 43(7):711-4. PubMed ID: 25934065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Efficacy of Antimicrobial Central Venous Catheters in Reducing Catheter-Related Bloodstream Infections in Adults: Abridged Cochrane Systematic Review and Network Meta-Analysis.
    Chong HY; Lai NM; Apisarnthanarak A; Chaiyakunapruk N
    Clin Infect Dis; 2017 May; 64(suppl_2):S131-S140. PubMed ID: 28475779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections.
    Chaftari AM; El Zakhem A; Jamal MA; Jiang Y; Hachem R; Raad I
    BMC Infect Dis; 2014 Sep; 14():518. PubMed ID: 25253042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.